Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

Eli Lilly's new experimental weight loss drug retatrutide yielded up to 28% weight loss, which is greater than that of ...

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works ...

Lilly’s new obesity drug produced roughly 28% average weight loss in trials — big efficacy, real safety and access questions.

Having one stroke is scary and life-threatening enough. But according to the Centers for Disease Control and Prevention, ...

TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.

Balasegaram is executive director of the Global Antibiotic Research & Development Partnership. No matter how carefully we use the antibiotics we have, drug resistant infections will continue to gain ...